Kura Oncology News

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)

TipRanksMay 3 11:34 ET

Express News | Wedbush Reiterates Outperform on Kura Oncology, Maintains $37 Price Target

BenzingaMay 3 09:42 ET

Scotiabank Keeps Their Hold Rating on Kura Oncology (KURA)

TipRanksMay 3 07:43 ET

Barclays Remains a Buy on Kura Oncology (KURA)

TipRanksMay 3 06:42 ET

Buy Rating Affirmed for Kura Oncology Amid Strong Financials and Promising Clinical Milestones

TipRanksMay 3 06:28 ET

Kura Oncology Inc (KURA) (Q1 2024) Earnings Call Transcript Highlights: Key Financial and ...

Yahoo FinanceMay 3 04:03 ET

ARDX, TNDM and VIAV Are Among After Hour Movers

Seeking AlphaMay 2 17:18 ET

Express News | Kura Oncology Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 GAAP EPS Results

BenzingaMay 2 17:11 ET

Express News | Kura Oncology Inc: Qtrly Shr Loss $0.59

ReutersMay 2 16:58 ET

Express News | Kura Oncology Inc: $527 Mln in Cash, Cash Equivalents and Investments Provide Runway Into 2027

ReutersMay 2 16:58 ET

Express News | Kura Oncology Q1 2024 GAAP EPS $(0.59) Misses $(0.55) Estimate

BenzingaMay 2 16:19 ET

Express News | Kura Oncology Q1 Operating Expenses USD 54.452 Million

ReutersMay 2 16:05 ET

Kura Oncology 1Q Loss/Shr 59c >KURA

Kura Oncology 1Q Loss/Shr 59c >KURA

Dow JonesMay 2 16:05 ET

Sector Update: Health Care Stocks Advance Premarket Monday

Health care stocks were advancing premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was up 0.5% and the iShares Biotechnology ETF (IBB) was 0.8% higher recently. Vaxxinity (VAXX) was r

MT NewswiresApr 22 09:11 ET

Kura Oncology Says Potential Leukemia Drug Ziftomenib Gets FDA Breakthrough Therapy Designation

Kura Oncology (KURA) said Monday the US Food and Drug Administration has granted Breakthrough Therapy Designation for its potential leukemia drug ziftomenib.

MT NewswiresApr 22 08:17 ET

Kura Oncology Gets Breakthrough Designation For Leukemia Therapy

Kura Oncology said Monday it received a breakthrough therapy designation from regulators for ziftomenib, its potential treatment for a form of leukemia.

WSJApr 22 08:13 ET

Express News | Kura Oncology Shares Are Trading Higher After the Company Received FDA Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML

Moomoo 24/7Apr 22 07:39 ET

Kura Oncology's Ziftomenib, Has Been Granted FDA Breakthrough Therapy Designation For Relapsed/Refractory NPM1-mutant Acute Myeloid Leukemia

Kura Oncology's Ziftomenib, Has Been Granted FDA Breakthrough Therapy Designation For Relapsed/Refractory NPM1-mutant Acute Myeloid Leukemia

BenzingaApr 22 07:32 ET

Express News | Kura Oncology Inc - Registration-Directed Trial of Ziftomenib in Npm1-Mutant Aml on Track to Complete Enrollment by Mid-2024

Moomoo 24/7Apr 22 07:30 ET

Express News | Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in Npm1-Mutant Aml

Moomoo 24/7Apr 22 07:30 ET